Faculty

Helen Y Chu

Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Program Lead, Infectious Disease, Brotman Baty Institute, Medicine - Allergy and Infectious Dis.
Term Professorship, Medicine - Allergy and Infectious Dis.


Education

MPH Epidemiology, University of Washington, 2012
MD Medicine, Duke University Medical Center, Durham, NC, 2005
BA Cornell University, 2001

Research Areas

Research Interests

Dr. Chu's research is focused on maternal immunization, in particular vaccines against influenza and respiratory syncytial virus (RSV). She studies the virologic and immunologic correlates of protection from respiratory viral infections in pregnant women, infants, and older adults, and performs clinical trials of vaccine candidates in both domestic and international sites, including Nepal and Bangladesh. She has developed immunologic assays to study transplacental transfer and decay kinetics of RSV antibody, and nosocomial and household transmission of respiratory viruses by genotypic analysis and molecular sequencing.

Recent Publications (PubMed)

Advisory Committee on Immunization Practices at a Crossroads.
(2025 Jun 16)
JAMA
Asturias EJ, Brewer NT, Brooks O, Chen LH, Chu HY, Cineas S, Loehr J, Jamieson DJ, Kamboj M, Kuchel GA, Lyons K, Maldonado YA, Moser CA, Schechter R, Shaw AC, Talbot K, Zucker JR
Scenario Projections of Respiratory Syncytial Virus Hospitalizations Averted Due to New Immunizations.
(2025 Jun 2)
JAMA Netw Open 8(6): e2514622
Hansen CL, Lee L, Bents SJ, Perofsky AC, Sun K, Starita LM, Adler A, Englund JA, Chow EJ, Chu HY, Viboud C
Investigating Symptom Duration Using Current Status Data: A Case Study of Postacute COVID-19 Syndrome.
(2025 Jun 5)
Epidemiology
Wolock CJ, Jacob S, Bennett JC, Elias-Warren A, O'Hanlon J, Kenny A, Jewell NP, Rotnitzky A, Cole SR, Weil AA, Chu HY, Carone M
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities.
(2025 Aug 1)
Curr Opin Infect Dis 38(4): 300-304
Murray A, Chu HY
Infant CD4 T-cell response to SARS-CoV-2 mRNA vaccination is restricted in cytokine production and modified by vaccine manufacturer.
(2025 Apr 4)
bioRxiv
Peters MQ, Young AL, Stolarczuk JE, Glad M, Layton E, Logue JK, Minkah NK, Chu HY, Englund JA, Sather DN, Seshadri C, Kachikis A, Harrington WE
Show complete publication list